Active — Not RecruitingNot Applicable

Support C Post-Market Registry

Czechia, Germany282 participantsStarted 2025-07-09

Plain-language summary

To collect post marketing surveillance data on consecutive patients with coronary heart disease intended to be or treated by the drug eluting Support C PTCA balloon catheter when used according to the Instructions for Use. Data will be collected in order to assess the long term safety and performance of the Support C Drug Coated Balloon (DCB) in routine clinical practice.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. In case of major dissection requiring bailout stenting after DCB use the patients will be included in the registry and followed as per study schedule.
✓. If major dissection occurred after lesion preparation, but before DCB use and lesion was stented, the patient will not be included in the registry.

What they're measuring

Adjudicated, device-oriented, Target Lesion Failure (TLF)

Timeframe: 12 months post procedure

Trial details

NCT IDNCT06678490

SponsorOrbusNeich

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2027-02

View on ClinicalTrials.gov More Coronary Arteriosclerosis trials